SIGAL SMS EXPANDS ITS STUDY SITE NETWORK IN THE FIELD OF ONCOLOGY.
Research and development of treatment options in the field of oncology is worldwide of utmost importance.
Tremendous potential is focussed on ambulatory outpatient clinical conduction.
Patients, having oncological diagnoses express great interest in receiving new, ambulatory, treatment options fighting their disease. This means, patients would not be forced to leave their home for longer periods.
Therefore, SIGAL SMS, has taken the initiative to intensify outpatient study implementation within the field of oncology to offer patients the opportunity to grant access to new treatment options.
CLINICAL STUDIES WITH PRACTISING ONCOLOGISTS COULD BE THE SOLUTION.
Together with our study centre network, consistent of 25 study centres and 5 oncology centres, SIGAL SMS would like to sustainably foster outpatient oncology studies within Germany, together with practising oncologists.
As
- - Expert in the field of ambulatory outpatient clinical conduction,
- - central interface between researching pharmaceutical companies and physicians
- - adviser and representation of interests simultaneously
- SIGAL SMS constitutes the link between all participants.
- Essential components of our business strategy encompasses medical progress within the outpatient oncology and the study implementation.
- - Are you a sponsor or CRO looking for study centres or partners to support you in implementing clinical trials within Germany?
- - Or are you a practising oncologist, looking for an opportunity to establish further within the field of research? Would you like to learn more about our initiative and all the opportunities?
- Don’t hesitate to contact us via E-Mail. We will get in touch with you as soon as possible.